choline alfoscerate
/ Generic mfg.
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 20, 2022
COALA: Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
(clinicaltrials.gov)
- P4 | N=630 | Recruiting | Sponsor: Daewoong Bio Inc.
New P4 trial • Alzheimer's Disease • CNS Disorders
1 to 1
Of
1
Go to page
1